Related Experiment Videos
Rhinovirus replication causes RANTES production in primary bronchial epithelial cells
M K Schroth1, E Grimm, P Frindt
1Department of Pediatrics, University of Wisconsin, Madison, Wisconsin 53792-4108, USA. mschroth@facstaff.wisc.edu
Summary
Rhinovirus (RV) replicates in lower airway cells, increasing inflammatory cytokine release. This suggests RV contributes to asthma-related respiratory symptoms and lower respiratory illnesses.
Area of Science:
- * Respiratory viral infections
- * Immunology
- * Cell biology
Background:
- * The precise mechanisms linking rhinovirus (RV) infections to lower airway symptoms in asthma patients remain unclear.
- * Understanding RV's impact on lung epithelial cells is crucial for respiratory health research.
Purpose of the Study:
- * To investigate the effects of RV infection on primary human bronchial epithelial (BE) cells.
- * To analyze viral replication, cell viability, and activation markers following RV exposure.
Main Methods:
- * Primary human bronchial epithelial (BE) cells were infected with RV16 or RV49 at different temperatures.
- * Viral replication was quantified using TCID50 assays.
- * Cell viability, cytokine secretion (RANTES, IL-8, GM-CSF), and cell surface marker expression (ICAM-1, HLA-DR) were measured.
Main Results:
- * Both RV16 and RV49 replicated in BE cells at 33°C and 37°C.
- * High-dose RV49 infection reduced cell viability and caused cytopathic effects.
- * RV infection significantly increased the secretion of RANTES, IL-8, and GM-CSF, along with RANTES mRNA levels, but did not alter ICAM-1 or HLA-DR expression.
Conclusions:
- * Rhinoviruses can replicate in lower airway epithelial cells, supporting their role in lower respiratory illnesses.
- * RV-induced cytokine release, particularly RANTES, may initiate antiviral responses.
- * These inflammatory responses could contribute to the pathogenesis of respiratory symptoms in individuals with asthma.